Recent news on Rilutek

Commencement of phase Ib clinical study for Myogane  -  May 17, 2007
Checkbiotech.org (press release),Riluzole (Rilutek(tm)), a glutamate modulator, is the only agent indicated for the treatment of this condition and increases average survival by only a few

Living with uncertainty  -  May 3, 2007
MaineToday.com,In studies, Rilutek has been shown to prolong the life of an individual with ALS by an average three months. On average, individuals with ALS live between

Caring for ALS Patient Brings Emotional Strain  -  Mar 19, 2007
drkoop.comJust one FDA-approved drug, Rilutek, has demonstrated some ability to slow the degenerative illness. Ongoing clinical trials are testing new ways to treat

Jim Steel’s long struggle  -  Mar 25, 2007
Toledo Blade,There is one FDA approved drug, Rilutek, that modestly slows the progression of ALS. There are several other drugs in clinical trials that show promise.

Implanting some hope  -  Mar 22, 2007
Newsday,The only federally approved drug for ALS, Rilutek, offers modest hope with an added two months of life, according to studies on the drug.

Meeting Adversity  -  Jan 31, 2007
Tonawanda News,Mary’s treatment includes Rilutek and occupational and speech therapy. She uses machines to help her breathe at night and clear her lungs during the day.

Vaccine May Lead to Lou Gehrig's Disease Treatment (Update2)  -  Jan 30, 2007
BloombergSanofi- Aventis SA's Rilutek medicine, approved in the US in 1995, is the only drug available that ``modestly slows the progression'' of the disease,

New treatment holds promise for potential ALS sufferers  -  Jan 30, 2007
Ottawa Citizen (subscription),Only one was found to have a modest effect, Rilutek (riluzole). It seems to prolong patients’ survival by about three months.

United States: Prior Art Need Not Be "Effective" To Be Enabling ...  -  Jan 8, 2007
Mondaq News Alerts (subcription),Riluzole is the chemical compound 6-trifluoromethoxy-2-benzothiazolamine, which is sold by Aventis under the trade name Rilutek® for treatment of

ALS patients become prisoners in their bodies  -  Jan 7, 2007
Salt Lake Tribune,Patients who can afford to take Rilutek, or the generic riluzole, generally live for an extra three to five months, the doctor explains.

The First Annual MBA ALS Basketball Challenge a Success  -  Dec 11, 2006
Harbus Online,Rilutek, made by Sanofi-Aventis and aimed at symptomatic ALS relief. Unfortunately, Rilutek may only extend life an average of two months.

ALS slows but doesn’t diminish Helen Wade  -  Dec 3, 2006
Jacksonville Daily Progress,...“I take meds (Rilutek) ... it’s not so bad,� Helen added. Wanting a second opinion, both Helen and Wendy searched for an ALS clinic which could help Helen.

A Fitness Mogul, Stricken by Illness, Hunts for Genes  -  Nov 29, 2006
Wall Street Journal (subscription),Mr. Nieto takes the only US-approved ALS drug, Rilutek, which can prolong survival for several months, and also a drug that can reduce mood swings in

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional